.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07E_IntestinalAntiinflammatoryAgents.A07EA01_Prednisolone.Prednisolone_1 .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07E_IntestinalAntiinflammatoryAgents.A07EA01_Prednisolone.Prednisolone_1| name: | Prednisolone_1 | |
| ATC code: | A07EA01_1 | route: | intravenous |
| compartments: | 2 | |
| dosage: | 20 | mg |
| volume of distribution: | 0.54 | L |
| clearance: | 0.22 | L/h/kg |
| other parameters in model implementation | ||
Prednisolone is a synthetic glucocorticoid used as an anti-inflammatory and immunosuppressive agent in the treatment of various conditions, including allergic disorders, autoimmune diseases, and inflammatory conditions. It is approved for clinical use and remains a widely prescribed corticosteroid.
Pharmacokinetic parameters reported in healthy adults following intravenous administration.
Petersen, KB, et al., & Schmiegelow, K (2003). Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology 51(6) 465–473. DOI:10.1007/s00280-003-0602-3 PUBMED:https://pubmed.ncbi.nlm.nih.gov/12698270
Honoré, PM, et al., & Spapen, HD (2014). What do we know about steroids metabolism and 'PK/PD approach' in AKI and CKD especially while on RRT--current status in 2014. Blood purification 38(2) 154–157. DOI:10.1159/000368390 PUBMED:https://pubmed.ncbi.nlm.nih.gov/25471548
Hill, MR, et al., & Brenner, AM (1990). Monitoring glucocorticoid therapy: a pharmacokinetic approach. Clinical pharmacology and therapeutics 48(4) 390–398. DOI:10.1038/clpt.1990.167 PUBMED:https://pubmed.ncbi.nlm.nih.gov/2225699